Literature DB >> 2036713

Doxorubicin toxicity in perfused rat heart. Decreased cell death at low oxygen tension.

P E Ganey1, L S Carter, R A Mueller, R G Thurman.   

Abstract

The purpose of these studies was to test whether O2 tension influences cardiotoxicity due to doxorubicin. Isolated hearts were perfused by the method of Langendorff at constant pressure with Krebs-Henseleit buffer saturated with 5% CO2 and either 95% or 20% O2. Toxicity due to doxorubicin was evaluated from changes in heart rate and from uptake of trypan blue by nonviable nuclei. Heart rate was stable in control hearts perfused at 95% O2 for 30 minutes but decreased in hearts perfused at 20% O2. Doxorubicin (30 microM) increased O2 uptake due to redox cycling by approximately 75 mumol/g/hr at 95% O2 but had no effect in hearts perfused at 20% O2. Heart rate decreased during 30 minutes of perfusion with doxorubicin and 95% or 20% O2, with greater decreases occurring with 95% than 20% O2 compared with values for the respective untreated controls. Irreversible cell damage indexed from uptake of vital dye due to doxorubicin was threefold greater than control at 95% O2 but was not different from control at at 20% O2. These data are consistent with the hypothesis that O2 tension is an important determinant of toxicity due to doxorubicin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036713     DOI: 10.1161/01.res.68.6.1610

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity.

Authors:  Jinping Gao; Ye Xiong; Ye-Shih Ho; Xuwan Liu; Chu Chang Chua; Xingshun Xu; Hong Wang; Ronald Hamdy; Balvin H L Chua
Journal:  Biochim Biophys Acta       Date:  2008-06-11

2.  Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.

Authors:  Guo-Chang Fan; Xiaoyang Zhou; Xiaohong Wang; Guojie Song; Jiang Qian; Persoulla Nicolaou; Guoli Chen; Xiaoping Ren; Evangelia G Kranias
Journal:  Circ Res       Date:  2008-10-23       Impact factor: 17.367

3.  MicroRNA‑133b alleviates doxorubicin‑induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2.

Authors:  Zhen Li; Zekang Ye; Jiazheng Ma; Qian Gu; Jianzhen Teng; Xiaoxuan Gong
Journal:  Int J Mol Med       Date:  2021-05-13       Impact factor: 4.101

4.  Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex.

Authors:  Naoshad Mohammad; Shivendra Vikram Singh; Parmanand Malvi; Balkrishna Chaube; Dipti Athavale; Muralidharan Vanuopadath; Sudarslal Sadasivan Nair; Bipin Nair; Manoj Kumar Bhat
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

5.  Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor.

Authors:  Mayel Gharanei; Afthab Hussain; Omar Janneh; Helen Maddock
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

6.  Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation.

Authors:  Zhi-feng Zhu; Li-juan Chen; Rong Lu; Jing Jia; Yu Liang; Qiong Xu; Chun-lei Zhou; Li Wang; Song Wang; Zhi Yao
Journal:  BMC Cancer       Date:  2008-11-25       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.